Logo (Actavis) 155 (Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base))

Pill imprint Logo (Actavis) 155 has been identified as Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base).

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual)

Imprint:

Logo (Actavis) 155

Strength:

8 mg (base) / 2 mg (base)

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Narcotic analgesic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

3 - Moderate abuse potential

Manufacturer:

Actavis Elizabeth LLC

National Drug Code (NDC):

00228-3155

Inactive Ingredients:

citric acid anhydrous
crospovidone
lactose monohydrate
magnesium stearate
mannitol
corn starch
povidone
sodium citrate
sucralose

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.